Keytruda Now Approved Website Oct 7, 2015Mar 5, 2018 Brand: Keytruda (pembrolizumab), Injection Parent Company: Merck Drug Type: Prescription Drug Category: Oncology Campaign: now-approved, Launch Targeting: HCPs, Patients Patient Website: https://www.keytruda.com/ HCP Website: https://www.keytruda.com/hcp/ Homepage for Indication Selection Patient Homepage for Melanoma Indication New Approved Indication – Patient Homepage HCP Homepage for New Approved Indication HCP Homepage for Melanoma Indication